BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 19084699)

  • 1. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
    Léauté-Labrèze C; Taïeb A
    Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol for orbital hemangioma.
    Taban M; Goldberg RA
    Ophthalmology; 2010 Jan; 117(1):195-195.e4. PubMed ID: 20114117
    [No Abstract]   [Full Text] [Related]  

  • 3. High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol.
    Hadaschik E; Scheiba N; Engstner M; Flux K
    J Cutan Pathol; 2012 Sep; 39(9):881-3. PubMed ID: 22764832
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe infantile haemangioma: complications and treatment.
    Heaton P; Kennedy C; Amin S
    J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
    Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
    Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of infantile hemangioma after termination of propranolol treatment.
    Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
    Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol for complicated infantile haemangiomas: a case series of 30 infants.
    Manunza F; Syed S; Laguda B; Linward J; Kennedy H; Gholam K; Glover M; Giardini A; Harper JI
    Br J Dermatol; 2010 Feb; 162(2):466-8. PubMed ID: 20055816
    [No Abstract]   [Full Text] [Related]  

  • 8. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
    Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
    J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
    Phillips RJ; Lokmic Z; Crock CM; Penington A
    J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on infantile hemangiomas.
    Lee KC; Bercovitch L
    Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
    Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
    J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary haemangioma successfully treated with oral beta-blocker in Dar es Salaam, Tanzania: a case report.
    Cloke A; Lim LT; Blaikie A
    Semin Ophthalmol; 2013 Jan; 28(1):32-3. PubMed ID: 23305438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 18. Current concepts in the management of periocular infantile (capillary) hemangioma.
    Ni N; Guo S; Langer P
    Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol Use for Infantile Hemangiomas.
    Ryan J
    Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.